1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsOvarian Cancer Clinical Trial Academy – Early-Career Investigator Award is sponsored by Department of Defense Ovarian Cancer Research Program (OCRP). Provides support for early-career investigators to develop and conduct clinical trials in ovarian cancer.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - DOD Ovarian Cancer, Clinical Trial Academy – Early-Career Investigator Award DOD Ovarian Cancer, Clinical Trial Academy – Early-Career Investigator Award Agency: Defense Health Agency Contracting Activity - DHACA Assistance Listings: 12. 420 -- Military Medical Research and Development Last Updated: May 13, 2026 View version history on Grants.
gov Summary: The Ovarian Cancer Clinical Trial Academy (OCCTA) supports the next generation of Early-Career Investigators (ECIs) in clinical trial research to produce effective treatments and cures for ovarian cancer.
The OCCTA, through its Leadership, provides for professional and leadership development of the ECIs to include skills and competencies needed to execute clinical trials, providing intensive mentoring, national networking, collaborations, and a peer group for junior clinical trialists.
The OCCTA will bring together established investigators (the Academy Dean and Assistant Dean), established Career Guides (mentors), and a group of ECIs/Scholars to conduct successful, highly productive clinical trials in ovarian cancer. Distinctive Features: Research funded under this FY25 funding opportunity will support translational research and small-scale, early-phase clinical trials in ovarian cancer.
Preliminary data are required, however, these data do not necessarily need to be derived from the ovarian cancer research field. ECI must be within 12 years of last postdoctoral research position (Ph. D.)
, clinical fellowship (M. D.) , or equivalent at the time of full application submission deadline.
Must commit no less than 25% effort to this award and/or OCCTA activities for the first 2 years. The Designated Mentor must be a clinical trialist with a strong record of mentoring and training early-career investigators. Grantor contact information File name Description Last updated OCRP_FY25_OCCTA-ECI_Eligibility_Statement.
pdf FY25 OCRP OCCTAECI Eligibility Statement Apr 22, 2025 02:04 PM UTC HT942525OCRPOCCTAECI_GG.
pdf FY25 OCRP OCCTAECI Program Announcement Apr 22, 2025 12:46 PM UTC Link to additional information Archived: October 11, 2025 Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Science technology and other research and development Your account requires additional identity verification.
According to the current listing, eligibility includes: Nonprofit organizations, including universities and research institutions. Confirm the full requirements in the official notice before applying.
Applications for Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award are due October 1, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award is funded by Department of Defense Ovarian Cancer Research Program (OCRP). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
CDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleThe Department's FY26 SBIR/STTR Release 3 opened June 24 with roughly 37 topics across DARPA, the Navy, the Air Force, and the defense components, all closing July 22. The compressed four-week window is unforgiving, but the bigger mistake founders make is treating every component the same. Here is how to read the release, the eligibility rules that disqualify good companies, and why the component you target matters more than the topic you pick.
Read article